Literature DB >> 7573373

Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.

P Billing1, S Tahir, B Calfin, G Gagne, L Cobb, S Targan, A Vidrich.   

Abstract

Antineutrophil cytoplasmic antibodies (ANCAs) identified in the serum of 50 to 80% of ulcerative colitis (UC) patients yield a perinuclear staining pattern (pANCA) with alcohol-fixed neutrophils. The ANCAs of UC are distinguishable from those described for Wegener's granulomatosis and other vasculitidies. These various non-UC ANCAs recognize neutrophil granule constituents, but the antigenic moiety specific for the UC pANCA remains unknown. Although the perinuclear nature of some ANCA reactions is an artifact of the alcohol fixation of neutrophils, which causes cytoplasmic granules to redistribute around the nucleus, the UC pANCA reaction has been found not to be similarly affected. We postulated a nuclear localization for the UC-associated pANCA antigen and used both confocal laser microscopy and immunoelectron microscopy to examine the neutrophil reaction of UC-associated pANCA-containing sera. Confocal microscopy revealed a nuclear reaction for 88% (22/25) of the sera with 72% (18/25) showing the reaction localizing to the inner side of the nuclear (membrane) periphery. Immunoelectron microscopy showed that the UC-associated pANCA reaction localized primarily over chromatin concentrated toward the nuclear periphery, although the sera did not recognize double-stranded DNA. These results confirm the nuclear localization of the UC-associated pANCA antigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573373      PMCID: PMC1871001     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

2.  Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

Authors:  J Broekroelofs; A H Mulder; G F Nelis; B D Westerveld; J W Tervaert; C G Kallenberg
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

3.  Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.

Authors:  S Hardarson; D R Labrecque; F A Mitros; G A Neil; J A Goeken
Journal:  Am J Clin Pathol       Date:  1993-03       Impact factor: 2.493

4.  Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates.

Authors:  A H Mulder; J Broekroelofs; G Horst; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

5.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.

Authors:  G Cambridge; D S Rampton; T R Stevens; D A McCarthy; M Kamm; B Leaker
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

6.  p-ANCA as a diagnostic marker in ulcerative colitis.

Authors:  K Deusch; K Oberstadt; W Schaedel; M Weber; M Classen
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

7.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.

Authors:  M Oudkerk Pool; P M Ellerbroek; B U Ridwan; R Goldschmeding; B M von Blomberg; A S Peña; K M Dolman; H Bril; W Dekker; J J Nauta
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 8.  Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.

Authors:  P Lesavre; L H Noël; S Gayno; P Nusbaum; D Reumaux; S Erlinger; J P Grünfeld; L Halbwachs-Mecarelli
Journal:  J Autoimmun       Date:  1993-04       Impact factor: 7.094

9.  Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.

Authors:  J W Tervaert; L Mulder; C Stegeman; J Elema; M Huitema; H The; C Kallenberg
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 10.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

View more
  12 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 3.  Recent advances in the diagnosis and classification of inflammatory bowel disease.

Authors:  Eric Vasiliauskas
Journal:  Curr Gastroenterol Rep       Date:  2003-12

Review 4.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

5.  pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.

Authors:  L K Gordon; M Eggena; G N Holland; J M Weisz; J Braun
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

6.  Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.

Authors:  P Yang
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

7.  Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.

Authors:  B Wei; H Dalwadi; L K Gordon; C Landers; D Bruckner; S R Targan; J Braun
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.

Authors:  B Terjung; H J Worman; V Herzog; T Sauerbruch; U Spengler
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

9.  Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis.

Authors:  J Mallolas; M Esteve; E Rius; E Cabré; M A Gassull
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 10.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.